The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

被引:7
作者
Pharaon, Rebecca R. [1 ]
Xing, Yan [1 ]
Agulnik, Mark [1 ]
Villaflor, Victoria M. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
immunotherapy; head and neck cancer; oropharyngeal squamous cell carcinoma; nasopharyngeal carcinoma; viral-associated cancers; human papillomavirus; Epstein-Barr virus; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; NASOPHARYNGEAL CARCINOMA; OPEN-LABEL; OROPHARYNGEAL CANCER; ANTITUMOR-ACTIVITY; METASTATIC HEAD; PLUS CETUXIMAB;
D O I
10.3389/fonc.2021.649963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A subset of head and neck cancers arising in the oropharynx and the nasopharynx are associated with human papillomavirus or Epstein-Barr virus. Unfortunately, limited treatment options exist once patients develop recurrent or metastatic disease in these cancers. Interest has risen in utilizing novel strategies including combination immune checkpoint inhibitors, vaccines, and adoptive cellular therapy, to improve treatment response and outcomes. Several ongoing studies are investigating the potential to overcome resistance to standard of care chemoradiation therapy with monotherapy or combination immunotherapy strategies in these viral-associated head and neck cancers.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Biomarkers for immunotherapy response in head and neck cancer [J].
Gavrielatou, Niki ;
Doumas, Stergios ;
Economopoulou, Panagiota ;
Foukas, Periklis G. ;
Psyrri, Amanda .
CANCER TREATMENT REVIEWS, 2020, 84
[22]   Combining Radiotherapy and Immunotherapy in Head and Neck Cancer [J].
Runnels, Juliana ;
Bloom, Julie R. ;
Hsieh, Kristin ;
Dickstein, Daniel R. ;
Shi, Yuhao ;
Jones, Brianna M. ;
Lehrer, Eric J. ;
Bakst, Richard L. .
BIOMEDICINES, 2023, 11 (08)
[23]   Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer [J].
Le, Xiuning ;
Ferrarotto, Renata ;
Wise-Draper, Trisha ;
Gillison, Maura .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07) :899-906
[24]   The role of surgery for HPV-associated head and neck cancer [J].
Mydlarz, Wojciech K. ;
Chan, Jason Y. K. ;
Richmon, Jeremy D. .
ORAL ONCOLOGY, 2015, 51 (04) :305-313
[25]   Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting [J].
Bauman, Julie E. ;
Cohen, Ezra ;
Ferris, Robert L. ;
Adelstein, David J. ;
Brizel, David M. ;
Ridge, John A. ;
O'Sullivan, Brian ;
Burtness, Barbara A. ;
Butterfield, Lisa H. ;
Carson, William E. ;
Disis, Mary L. ;
Fox, Bernard A. ;
Gajewski, Thomas F. ;
Gillison, Maura L. ;
Hodge, James W. ;
Quynh-Thu Le ;
Raben, David ;
Strome, Scott E. ;
Lynn, Jean ;
Malik, Shakun .
CANCER, 2017, 123 (07) :1259-1271
[26]   Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review [J].
Guidi, Alessandro ;
Codeca, Carla ;
Ferrari, Daris .
MEDICAL ONCOLOGY, 2018, 35 (03)
[27]   EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy [J].
Kang, James J. ;
Ko, Albert ;
Kil, Sang Hoon ;
Clair, Jon Mallen-St. ;
Shin, Daniel Sanghoon ;
Wang, Marilene B. ;
Srivatsan, Eri S. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01)
[28]   Immunotherapy in head and neck cancer: aiming at EXTREME precision [J].
Szturz, Petr ;
Vermorken, Jan B. .
BMC MEDICINE, 2017, 15
[29]   Human papilloma virus associated head and neck cancer: A PCR based study [J].
Barwad, Adarsh ;
Sood, Swati ;
Gupta, Nalini ;
Rajwanshi, Arvind ;
Panda, Naresh ;
Srinivasan, Radhika .
DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (10) :893-897
[30]   Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review) [J].
Wei, Chun ;
Lan, Xiaojun ;
Qiu, Maona ;
Cui, Ran ;
Fu, Qiuxia ;
Shinge, Shafiu A. Umar ;
Muluh, Tobias Achu ;
Jiang, Ou .
ONCOLOGY LETTERS, 2023, 26 (03)